Jingfeng Bi

机构：Chinese PLA General Hospital, Beijing Tian Tan Hospital, National Clinical Research Center for Digestive Diseases · ORCID：0000-0002-4114-4372

发表论文 41 篇 · 总被引 1872 次 · h-index 13

代表论文

• Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B (2022 · Journal of Hepatology · 被引 72)
• Prediction of biochemical nonresolution in patients with chronic drug‐induced liver injury: A large multicenter study (2021 · Hepatology · 被引 38)
• Corticosteroid plus glycyrrhizin therapy for chronic drug‐ or herb‐induced liver injury achieves biochemical and histological improvements: a randomised open‐label trial (2022 · Alimentary Pharmacology & Therapeutics · 被引 33)
• Exosome: A Review of Its Classification, Isolation Techniques, Storage, Diagnostic and Targeted Therapy Applications (2020 · DOAJ (DOAJ: Directory of Open Access Journals) · 被引 16)
• Microstructural and functional impairment of the basal ganglia in Wilson’s disease: a multimodal neuroimaging study (2023 · Frontiers in Neuroscience · 被引 13)
• Clinical features, microbial spectrum, and antibiotic susceptibility patterns of spontaneous bacterial peritonitis in cirrhotic patients (2023 · Digestive and Liver Disease · 被引 8)